[Aspirin-induced asthma].
Sakakibara
H
H
Division of Respirology and Allergology, Department of Internal Medicine, Fujita-Health University School of Medicine.
D000318:Adrenergic beta-Agonists / Q000627:therapeutic use; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects*; D001241:Aspirin / Q000009:adverse effects*; D001249:Asthma / Q000139:chemically induced* / Q000175:diagnosis / Q000628:therapy; D016861:Cyclooxygenase Inhibitors; D003937:Diagnosis, Differential; D015232:Dinoprostone / Q000502:physiology; D006801:Humans; D015289:Leukotrienes / Q000502:physiology; D011379:Prognosis; D013806:Theophylline / Q000627:therapeutic use
D000318:Adrenergic beta-Agonists; D000894:Anti-Inflammatory Agents, Non-Steroidal; D016861:Cyclooxygenase Inhibitors; D015289:Leukotrienes; D013806:Theophylline; D015232:Dinoprostone; D001241:Aspirin